Your Article Summary
GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT
GlaxoSmithKline, 10/06/09
GlaxoSmithKline announced that the United States Food and Drug Administration’s Oncologic Drugs Advisory Committee voted unanimously in support of the approval of VOTRIENT. Specifically, the panel voted that the benefit–to–risk profile is acceptable for patients with advanced renal cell carcinoma. Pazopanib is an investigational, oral treatment for patients with advanced RCC.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Article Search
Sponsor


See Latest Articles


